Table 2 Characteristics of the cohort.
From: Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids
Patient number | Sex M/F | Age (y) | Underlying nephropathy | Comorbidities | Medication | Dry weight (kg) | Dialyser surface area(m2) | Dialysis Duration (h) | Kt/V | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ischemic cardio-myopathy | Diabetes mellitus | Beta-blockers | Calcium antagonists | Alpha-blockers | ACE-inhibitors or ARB | ||||||||
1 | F | 75 | Diabetic nephropathy | Y | Y | Y | N | Y | Y | 72.5 | 1.8 | 3.0 | 1.51 |
2 | F | 88 | Diabetic nephropathy | N | Y | Y | Y | Y | Y | 60.0 | 1.8 | 3.0 | 1.48 |
3 | M | 59 | Diabetic nephropathy | Y | Y | Y | N | N | Y | 100.5 | 1.8 | 4.0 | 1.44 |
4 | M | 71 | Nephroangiosclerosis | Y | N | Y | N | N | Y | 69.5 | 1.8 | 4.0 | 1.66 |
5 | M | 59 | Focal segmental glomerulosclerosis | N | N | Y | Y | Y | N | 79.5 | 1.8 | 3.5 | 1.46 |
6 | M | 88 | Nephroangiosclerosis | N | N | Y | N | N | N | 76.0 | 1.4 | 4.0 | 1.52 |
7 | F | 86 | Nephroangiosclerosis | Y | N | Y | N | N | Y | 43.0 | 1.8 | 3.0 | 1.59 |
8 | M | 81 | Nephroangiosclerosis | N | N | Y | Y | N | N | 79.0 | 1.8 | 3.5 | 1.38 |
9 | F | 74 | Diabetic nephropathy | N | Y | N | Y | N | N | 81.0 | 1.8 | 3.5 | 1.76 |
10 | M | 64 | Nephroangiosclerosis | N | N | Y | N | N | N | 98.0 | 1.8 | 3.5 | 1.41 |
11 | M | 74 | Nephroangiosclerosis | N | N | N | N | N | N | 69.5 | 1.8 | 4.0 | 1.52 |
12 | F | 66 | Trombotic microangiopathy | N | N | N | Y | N | Y | 52.0 | 1.8 | 3.5 | 1.90 |
13 | M | 65 | Focal segmental glomerulosclerosis | N | N | Y | N | N | N | 87.2 | 1.8 | 4.0 | 2.08 |
14 | M | 72 | Nephroangiosclerosis | Y | N | N | N | N | Y | 92.0 | 1.8 | 3.0 | 1.00 |
15 | F | 75 | Diabetic nephropathy | N | Y | Y | Y | Y | Y | 48.0 | 1.8 | 3.5 | 1.56 |
16 | M | 77 | Proliferative glomerulonephritis | Y | N | Y | N | N | Y | 80.5 | 1.8 | 3.0 | 1.07 |
17 | M | 72 | Diabetic nephropathy | Y | Y | N | N | N | Y | 89.5 | 1.8 | 4.0 | 1.37 |
18 | F | 65 | Diabetic nephropathy | Y | Y | Y | Y | Y | Y | 48.0 | 1.8 | 3.5 | 2.08 |
19 | F | 56 | Nephroangiosclerosis | N | N | Y | Y | N | Y | 65.0 | 1.8 | 3.5 | 2.07 |
20 | F | 48 | IgA nephropathy | N | Y | Y | N | N | N | 60.0 | 1.8 | 3.5 | 2.20 |
21 | F | 70 | Nephroangiosclerosis | N | N | N | Y | N | Y | 47.5 | 1.8 | 3.5 | 2.00 |
22 | F | 64 | Relapsing pyelonephritis | N | N | Y | Y | Y | Y | 55.0 | 1.8 | 3.3 | 2.22 |
23 | M | 68 | IgA nephropathy | Y | N | N | Y | N | N | 94.5 | 1.8 | 4.0 | 1.52 |
24 | M | 71 | Nephroangiosclerosis | Y | Y | Y | N | N | N | 75.5 | 1.8 | 4.5 | 1.70 |